chevron_left
Companies To Watch: The $1 Trillion Opportunity: Rethinking Investment in Women’s Health
Speakers
Despite representing half the global population, women continue to face systemic inequities in health research and funding. Conditions that disproportionately affect women—such as migraines, cognitive disorders, and maternal health—remain underfunded, while clinical guidelines often fail to account for female-specific risk factors. Yet momentum is growing: landmark studies, targeted funding initiatives, and new policy frameworks are beginning to reshape the women’s health landscape.
In this edition of Companies to Watch, join healthcare and policy experts for a 60-minute discussion on the drivers of innovation in women’s health—and the strategies needed to close the equity gap globally.
Watch to learn:
- Funding: Why does women’s health remain chronically underfunded despite its $1 trillion economic potential—and how are new funding models shifting the balance?
- Research & diagnosis: How does gender bias in clinical research affect diagnosis, treatment, and long-term outcomes for women?
- Innovation catalysts: Which therapeutic areas and technologies are attracting new investment and advancing solutions in underserved conditions?
- Global equity: What strategies can sustain momentum worldwide and ensure that progress in women’s health extends beyond high-income markets?
- Policy & partnerships: How can governments, investors, and industry collaborate to accelerate equity while delivering measurable impact?
